Mineralys Therapeutics, Inc. (MLYS)

Last Three Months

26-Aug-24 -- 25-Nov-24

Time Period:

Three Months
|
Year

($352.44K) Net Amount

Buy:	0	--
Sell:	($352.44K)	$13.52 - $13.57

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

7

0

1

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Oct-24 4:22 PM View:	14-Oct-24 Option Exercise $5.78K	Rodman David Malcom Chief Medical Officer		Mineralys Therapeutics, Inc. - MLYS	19% 114.24K to 135.97K	0	0	--	--	Show Txns Hide Txns

15-Oct-24 4:21 PM View:	11-Oct-24 Market Sale (Planned) ($206.43K)	Congleton Jon Chief Executive Officer Director		Mineralys Therapeutics, Inc. - MLYS	(2%) 911.21K to 895.94K	0	($206.43K) (2%)	--	$13.52	Show Txns Hide Txns

15-Oct-24 4:22 PM View:	11-Oct-24 Market Sale (Planned) ($146.00K)	Levy Adam Scott CFO and Secretary		Mineralys Therapeutics, Inc. - MLYS	(4%) 247.61K to 236.85K	0	($146.00K) (4%)	--	$13.57	Show Txns Hide Txns